Result of AGM

RUA Life Sciences PLC

28 August 2024

 

28 August 2024

RUA Life Sciences plc

("RUA" the "Company" or the "Group")

Result of AGM

RUA Life Sciences plc (AIM:RUA.L), the holding company of a group of medical device businesses focussed on the exploitation of the world's leading long-term implantable biostable polymer (Elast-Eon ™), announces that all resolutions put forward to its Annual General Meeting held yesterday were duly passed and the votes cast were as follows:

Res No.	Votes For	%	Votes Against	%	Votes Withheld
01	6,051,300	99.37%	38,570	0.63%	0
02	6,050,279	99.36%	38,783	0.64%	808
03	6,051,300	99.37%	38,570	0.63%	0
04	6,045,927	99.28%	43,943	0.72%	0
05	6,045,698	99.27%	44,172	0.73%	0
06	5,941,757	97.57%	148,113	2.43%	0
07	5,941,757	97.57%	148,113	2.43%	0

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the Company's website (www.rualifesciences.com).

For further information contact:

RUA Life Sciences	Tel: [phone]
Bill Brown, CEO
Lachlan Smith, CFO
Cavendish Capital Markets Limited
(Nominated Adviser and Broker)	Tel: [phone]
Giles Balleny/Dan Hodkinson (Corporate Finance)
Charlie Combe (Broking)
Michael Johnson (Sales)

 

END